Component

Rat RBL-2H3 degranulation

Rat RBL-2H3 degranulation

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. RA reduced histamine and beta-hexosaminidase release in IgE-activated rat RBL-2H3 cells.

    Rosmarinic acid → Rat RBL-2H3 degranulation Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    experimental_contrast
    {"intervention": "RA plus IgE activation", "comparator": "IgE activation without RA", "endpoint": "RA reduced histamine and beta-hexosaminidase release in IgE-activated rat RBL-2H3 cells.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; recorded from source.
    experimental_model
    2024 RBL-2H3 study; primary abstract, dose/timing not extracted.
    interpretation_status
    Recorded from source with stated access limits; ungraded, not independent replication.
    limitations
    Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
    nutrient_topic
    Rosmarinic acid collection; exact intervention and molecular form govern interpretation. · Rosmarinic acid
    plain_language
    RA reduced histamine and beta-hexosaminidase release in IgE-activated rat RBL-2H3 cells.
    primary_references
    Inhibitory effect of rosmarinic acid on IgE-trigged mast cell degranulation in vitro and in vivo. | https://pubmed.ncbi.nlm.nih.gov/38270683/ | https://doi.org/10.1007/s11033-023-09164-z
    source_locator
    Reviewed reference ra-mast-release; No directly verified Lyn/Syk target is assigned.

    Rosmarinic acid: detailed mechanisms of action (reviewed 10 October 2026) · lines 253–259

    AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · 2024 RBL-2H3 study; primary abstract, dose/timing not extracted. · Recorded from source · Recorded from source

    ### ra-mast-release RA reduced histamine and beta-hexosaminidase release in IgE-activated rat RBL-2H3 cells. No directly verified Lyn/Syk target is assigned. Model and exposure: 2024 RBL-2H3 study; primary abstract, dose/timing not extracted. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Inhibitory effect of rosmarinic acid on IgE-trigged mast cell degranulation in vitro and in vivo. | 2024 | https://pubmed.ncbi.nlm.nih.gov/38270683/ | https://doi.org/10.1007/s11033-023-09164-z | Access: Indexed primary abstract/metadata only; unextracted doses, figures and methods remain unknown.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.